BlackRock’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.6M Buy
8,501,708
+232,865
+3% +$886K ﹤0.01% 2833
2025
Q4
$28.7M Buy
8,268,843
+2,617,984
+46% +$11.6M ﹤0.01% 2868
2025
Q3
$31.3M Buy
5,650,859
+1,165,031
+26% +$4.73M ﹤0.01% 2805
2025
Q2
$11.1M Buy
4,485,828
+179,617
+4% +$277K ﹤0.01% 3362
2025
Q1
$8.57M Sell
4,306,211
-218,573
-5% -$558K ﹤0.01% 3390
2024
Q4
$13.2M Sell
4,524,784
-741,991
-14% -$2.6M ﹤0.01% 3275
2024
Q3
$20.4M Buy
5,266,775
+156,357
+3% +$724K ﹤0.01% 3029
2024
Q2
$26.3M Buy
5,110,418
+1,354,208
+36% +$8.21M ﹤0.01% 2813
2024
Q1
$26.3M Sell
3,756,210
-22,408
-0.6% -$170K ﹤0.01% 2829
2023
Q4
$33.5M Buy
3,778,618
+444,093
+13% +$3.42M ﹤0.01% 2727
2023
Q3
$31.8M Buy
3,334,525
+445,309
+15% +$5.78M ﹤0.01% 2669
2023
Q2
$42.3M Buy
2,889,216
+1,375,093
+91% +$19.2M ﹤0.01% 2590
2023
Q1
$18.6M Buy
1,514,123
+26,277
+2% +$428K ﹤0.01% 3014
2022
Q4
$27.6M Buy
+1,487,846
New +$26.9M ﹤0.01% 2853

Other funds holding PRME